Respiratory syncytial virus vaccination among US adults aged ≥60 years.

ABSTRACT:

Background

Respiratory syncytial virus (RSV) vaccines have been recommended for US adults aged ≥60 years for nearly one year. However, the extent of vaccination coverage and the factors influencing uptake remain underexplored. This study aimed to evaluate national and state-specific RSV vaccination coverage among US adults aged ≥60 years and to identify demographic and socioeconomic factors that influence vaccination uptake.

Methods

This cross-sectional study analyzed data from the US Census Household Pulse Survey, from January 9 to March 4, 2024, which included 49,322 adults aged ≥60 years. Participants self-reported their RSV vaccination status along with demographic and socioeconomic information. Multivariable Poisson regression was used to identify factors associated wit

SUBMITTER: Geng X 

PROVIDER: S-EPMC11649540 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature